Author:
Perrier d'Hauterive S.,Charlet-Renard C.,Berndt S.,Dubois M.,Munaut C.,Goffin F.,Hagelstein M.-T.,Noël A.,Hazout A.,Foidart J.-M.,Geenen V.
Publisher
Oxford University Press (OUP)
Subject
Obstetrics and Gynaecology,Rehabilitation,Reproductive Medicine
Reference63 articles.
1. Arici A, Engin O, Attar E and Olive DL (1995) Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in human endometrium. J Clin Endocrinol Metab80, 1908–1915.
2. Bhattacharya S, Banerjee J, Sen S and Manna PR (1993) Human chorionic gonadotropin binding sites in the human endometrium. Acta Endocrinol129, 15–19.
3. Bonnamy PJ, Benhaim A and Leymarie P (1990) Estrous cycle-related changes of high affinity luteinizing hormone/human chorionic gonadotropin binding sites in the rat uterus. Endocrinol126, 1264–1269.
4. Bonnamy PJ, Benhaim A and Leymarie P (1993) Uterine luteinizing hormone/human chorionic gonadotropin-binding sites in the early pregnant rat uterus: evidence for total occupancy in the periimplantation period. Endocrinol132, 1240–1246.
5. Casslén B, Sandberg T, Gustavsson B, Willén R and Nilbert M (1998) Transforming growth factor beta1 in the human endometrium. Cyclic variation, increased expression by estradiol and progesterone, and regulation of plasminogen activators and plasminogen activator inhibitor-1. Biol Reprod58, 1343–1350.